BASIC MECHANISMS OF SEIZURES
癫痫发作的基本机制
基本信息
- 批准号:2262693
- 负责人:
- 金额:$ 84.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1979
- 资助国家:美国
- 起止时间:1979-01-01 至 2000-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This is a proposal to continue a very successful and highly productive
program project entitled "Basic Mechanisms of Seizures". The overall goal
of this program is to characterize structure-activity relationships,
mechanisms and sites of action, and neurologic effects of alkyl-
substituted butyrolactones and related compounds--a newly discovered class
of neuroactive chemicals. Initial studies have demonstrated that these
compounds can modulate the action of GABA, the major inhibitory
neurotransmitter in mammalian CNS, by affecting its action at the GABA-A
receptor-chloride ionophore. Several highly effective and widely used
neurotropic drugs, particularly benzodiazepines and barbiturates, also act
at the GABA-A receptor. This program tests the hypothesis that alkyl
substituted butyrolactones have sites and mechanisms of action different
from other compounds acting at the GABAA receptor-chloride ionophore and
as a result of these distinct actions, these compounds have considerable
potential for development as improved neurotropic therapeutic agents.
The present program consists of three integrated component projects, a
scientific (molecular biology) core and an administrative core. The major
goals of the component projects are: 1 )To identify and synthesize new
neuroactive alkyl-substituted butyrolactones and structurally related
compounds and characterize their structure-activity relationships 2) To
characterize the molecular sites and mechanisms of action and neurologic
effects of alkyl-substituted butyrolactones and related compounds; and 3)
To characterize the functional sites and mechanisms of action of alkyl-
substituted butyrolactones and related compounds. These studies will
utilize synthetic organic chemistry, neuropharmacology, electrophysiology,
molecular biology and neuroanatomical methods and techniques. Our program
brings together a group of experienced, talented and productive medical
scientists who have special knowledge and research skills which make them
particularly suited to carry out our goals. We have already demonstrated
that we can work well together and can direct closely inter-related and
complementary research projects.
Our research should improve the understanding of the GABA-A receptor-
chloride ionophore and other receptors in brain, help explain normal and
abnormal GNS function and identify new drugs for the treatment of
neurologic and psychiatric disorders including seizures and epilepsy.
这是一项非常成功和卓有成效的提案
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES A FERRENDELLI其他文献
JAMES A FERRENDELLI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES A FERRENDELLI', 18)}}的其他基金
MOLECULAR & BEHAVIORAL NEUROPHARMACOLOGY OF BUTYROLACTONES & RELATED COMPOUNDS
分子
- 批准号:
6204991 - 财政年份:1999
- 资助金额:
$ 84.86万 - 项目类别:
MOLECULAR & BEHAVIORAL NEUROPHARMACOLOGY OF BUTYROLACTONES & RELATED COMPOUNDS
分子
- 批准号:
6112107 - 财政年份:1998
- 资助金额:
$ 84.86万 - 项目类别:
MOLECULAR & BEHAVIORAL NEUROPHARMACOLOGY OF BUTYROLACTONES & RELATED COMPOUNDS
分子
- 批准号:
6243469 - 财政年份:1997
- 资助金额:
$ 84.86万 - 项目类别:
相似海外基金
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10004277 - 财政年份:2020
- 资助金额:
$ 84.86万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10475298 - 财政年份:2020
- 资助金额:
$ 84.86万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10693904 - 财政年份:2020
- 资助金额:
$ 84.86万 - 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10013749 - 财政年份:2020
- 资助金额:
$ 84.86万 - 项目类别:
Study on how anticonvulsants affect car driving
抗惊厥药如何影响汽车驾驶的研究
- 批准号:
20K17977 - 财政年份:2020
- 资助金额:
$ 84.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10266034 - 财政年份:2020
- 资助金额:
$ 84.86万 - 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10475109 - 财政年份:2020
- 资助金额:
$ 84.86万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10248384 - 财政年份:2020
- 资助金额:
$ 84.86万 - 项目类别:
Prevention of neuropathic pain by antidepressants and anticonvulsants: in vivo patch-clamp analysis
抗抑郁药和抗惊厥药预防神经性疼痛:体内膜片钳分析
- 批准号:
24592355 - 财政年份:2012
- 资助金额:
$ 84.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Anticonvulsants, ischemic seizures and regeneration in the immature brain
抗惊厥药、缺血性癫痫发作和未成熟大脑的再生
- 批准号:
8492175 - 财政年份:2009
- 资助金额:
$ 84.86万 - 项目类别: